BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30397360)

  • 1. Genetic variation determines VEGF-A plasma levels in cancer patients.
    Innocenti F; Jiang C; Sibley AB; Etheridge AS; Hatch AJ; Denning S; Niedzwiecki D; Shterev ID; Lin J; Furukawa Y; Kubo M; Kindler HL; Auman JT; Venook AP; Hurwitz HI; McLeod HL; Ratain MJ; Gordan R; Nixon AB; Owzar K
    Sci Rep; 2018 Nov; 8(1):16332. PubMed ID: 30397360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
    Hofmann G; Langsenlehner U; Renner W; Langsenlehner T; Yazdani-Biuki B; Clar H; Gerger A; Wehrschuetz M; Samonigg H; Krippl P
    J Cancer Res Clin Oncol; 2008 May; 134(5):591-5. PubMed ID: 17938959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
    Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
    Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
    Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
    Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor pathway in endometriosis: genetic variants and plasma biomarkers.
    Vodolazkaia A; Yesilyurt BT; Kyama CM; Bokor A; Schols D; Huskens D; Meuleman C; Peeraer K; Tomassetti C; Bossuyt X; Lambrechts D; D'Hooghe T; Fassbender A
    Fertil Steril; 2016 Apr; 105(4):988-96. PubMed ID: 26773192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of vascular endothelial growth factor single nucleotide polymorphisms on the prognosis of breast cancer patients.
    Rani J; Rahul B; Ramesh G; Krishnamoorthy L; Shilpa C; Ramaswamy G; Deshmane V
    Indian J Cancer; 2014; 51(4):512-7. PubMed ID: 26842181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis.
    Garcia V; Garcia JM; Silva J; Peña C; Dominguez G; Lorenzo Y; Diaz R; Alonso I; Colas A; Hurtado A; Sanchez A; Bonilla F
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1165-71. PubMed ID: 18461364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer.
    Hansen TF; Spindler KL; Lorentzen KA; Olsen DA; Andersen RF; Lindebjerg J; Brandslund I; Jakobsen A
    J Cancer Res Clin Oncol; 2010 May; 136(5):751-8. PubMed ID: 19904558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.
    Bocci G; Man S; Green SK; Francia G; Ebos JM; du Manoir JM; Weinerman A; Emmenegger U; Ma L; Thorpe P; Davidoff A; Huber J; Hicklin DJ; Kerbel RS
    Cancer Res; 2004 Sep; 64(18):6616-25. PubMed ID: 15374976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab.
    Koutras AK; Antonacopoulou AG; Eleftheraki AG; Dimitrakopoulos FI; Koumarianou A; Varthalitis I; Fostira F; Sgouros J; Briasoulis E; Bournakis E; Bafaloukos D; Bompolaki I; Galani E; Kalogeras KT; Pectasides D; Fountzilas G; Kalofonos HP
    Pharmacogenomics J; 2012 Dec; 12(6):468-75. PubMed ID: 21844885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer.
    Yu HG; Zhong X; Yang YN; Luo HS; Yu JP; Meier JJ; Schrader H; Bastian A; Schmidt WE; Schmitz F
    Int J Colorectal Dis; 2004 Jan; 19(1):18-22. PubMed ID: 12827408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer.
    Duff SE; Saunders M; McCredie V; Kumar S; O'Dwyer ST; Jayson GC
    Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):367-71. PubMed ID: 16097569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma VEGF-A and its soluble receptor R1 correlate with the clinical stage of colorectal cancer.
    Myśliwiec P; Piotrowski Z; Zalewski B; Kukliński A; Pawlak K
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():85-7. PubMed ID: 15638384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF gene polymorphisms and susceptibility to colorectal cancer.
    Jannuzzi AT; Özhan G; Yanar HT; Alpertunga B
    Genet Test Mol Biomarkers; 2015 Mar; 19(3):133-7. PubMed ID: 25635747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of serum angiogenic activity in colorectal cancer patients.
    Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
    J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
    Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
    Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer.
    Hansen TF; Garm Spindler KL; Andersen RF; Lindebjerg J; Brandslund I; Jakobsen A
    Pharmacogenomics J; 2011 Feb; 11(1):53-60. PubMed ID: 20125120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells.
    Narita K; Fujii T; Ishiwata T; Yamamoto T; Kawamoto Y; Kawahara K; Nakazawa N; Naito Z
    Int J Oncol; 2009 Feb; 34(2):355-60. PubMed ID: 19148469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.